ZA991749B - Pharmaceutical composition for prophylaxis and therapy of diseases associated with ocular fundus tissue cytopathy. - Google Patents

Pharmaceutical composition for prophylaxis and therapy of diseases associated with ocular fundus tissue cytopathy.

Info

Publication number
ZA991749B
ZA991749B ZA9901749A ZA991749A ZA991749B ZA 991749 B ZA991749 B ZA 991749B ZA 9901749 A ZA9901749 A ZA 9901749A ZA 991749 A ZA991749 A ZA 991749A ZA 991749 B ZA991749 B ZA 991749B
Authority
ZA
South Africa
Prior art keywords
prophylaxis
therapy
pharmaceutical composition
diseases associated
ocular fundus
Prior art date
Application number
ZA9901749A
Other languages
English (en)
Inventor
Mitsuyoshi Azuma
Yukuo Yoshida
Yuji Sakamoto
Jun Inoue
Original Assignee
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharma Co filed Critical Senju Pharma Co
Publication of ZA991749B publication Critical patent/ZA991749B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Ophthalmology & Optometry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
ZA9901749A 1998-03-05 1999-03-04 Pharmaceutical composition for prophylaxis and therapy of diseases associated with ocular fundus tissue cytopathy. ZA991749B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5362498 1998-03-05

Publications (1)

Publication Number Publication Date
ZA991749B true ZA991749B (en) 1999-09-16

Family

ID=12948075

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9901749A ZA991749B (en) 1998-03-05 1999-03-04 Pharmaceutical composition for prophylaxis and therapy of diseases associated with ocular fundus tissue cytopathy.

Country Status (17)

Country Link
US (1) US6423691B1 (ja)
EP (2) EP1504760B1 (ja)
JP (1) JP4422894B2 (ja)
KR (1) KR20010041605A (ja)
CN (1) CN1298304A (ja)
AR (1) AR018576A1 (ja)
AT (2) ATE296635T1 (ja)
AU (1) AU2745599A (ja)
BR (1) BR9908566A (ja)
CA (1) CA2322854A1 (ja)
DE (2) DE69925578T2 (ja)
HU (1) HUP0101733A3 (ja)
ID (1) ID27083A (ja)
NO (1) NO20004405L (ja)
PL (1) PL343412A1 (ja)
WO (1) WO1999044624A2 (ja)
ZA (1) ZA991749B (ja)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1334718A4 (en) * 2000-10-26 2007-07-18 Senju Pharma Co DRUG COMPOSITION CONTAINING DIPEPTIDYL ALDEHYDE COMPOUND
DE60330038D1 (de) * 2002-07-22 2009-12-24 Senju Pharma Co Neue alpha-ketoamidderivate und deren verwendung
AU2003263436A1 (en) 2002-09-19 2004-04-08 Koninklijke Philips Electronics N.V. Electrowetting optical switch
AU2003292838A1 (en) * 2002-12-27 2004-07-29 Kirin Beer Kabushiki Kaisha Therapeutic agent for wet age-related macular degeneration
RU2580315C3 (ru) 2009-05-29 2021-06-18 Перл Терапьютикс, Инк. Композиции для респираторной доставки активных веществ и связанные с ними способы и системы
EP2541716A1 (en) 2010-02-25 2013-01-02 Panasonic Corporation Demand and supply control apparatus, demand and supply control method, and program
CN103052382B (zh) 2010-07-14 2014-10-22 千寿制药株式会社 α-酮酰胺衍生物的固体分散体
RU2452436C1 (ru) * 2011-01-31 2012-06-10 Федеральное государственное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова Федерального агентства по высокотехнологичной медицинской помощи" Способ лечения атрофии зрительного нерва сосудистого генеза
JPWO2015125941A1 (ja) * 2014-02-21 2017-03-30 株式会社ヘリオス 眼疾患治療剤、そのスクリーニング方法または網膜色素上皮細胞移植に伴う拒絶反応の予測方法
US10449234B2 (en) 2015-09-11 2019-10-22 The Schepens Eye Research Institute, Inc. Compositions and methods for prevention and treatment of corneal haze and scarring
US11439608B2 (en) 2017-09-25 2022-09-13 Qun Lu Roles of modulators of intersectin-CDC42 signaling in Alzheimer's disease
PL424452A1 (pl) * 2018-01-31 2019-08-12 Forty-Four Pharmaceuticals Spółka Z Ograniczoną Odpowiedzialnością Inhibitory obojętnej endopeptydazy (NEP) i ludzkiej rozpuszczalnej endopeptydazy (hSEP) do profilaktyki i leczenia chorób oczu

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0504938A3 (en) * 1991-03-22 1993-04-14 Suntory Limited Prophylactic and therapeutic agent for bone diseases comprising di- or tripeptide derivative as active ingredient
JP2848232B2 (ja) * 1993-02-19 1999-01-20 武田薬品工業株式会社 アルデヒド誘導体
JP3599287B2 (ja) 1993-04-28 2004-12-08 三菱化学株式会社 スルホンアミド誘導体
EP0731107A1 (en) 1995-02-13 1996-09-11 Takeda Chemical Industries, Ltd. Production of aldehyde derivatives
ATE230275T1 (de) * 1995-10-25 2003-01-15 Senju Pharma Co Angiogense-inhibitor
KR100490807B1 (ko) * 1995-11-28 2005-10-14 세파론, 인코포레이티드 시스테인및세린프로테아제의d-아미노산함유억제제
DE19718826A1 (de) * 1997-05-05 1998-11-12 Marion S Dr Eckmiller Verwendung biologisch aktiver Wirkstoffe zum Beeinflussen des Extrazellulär-Raumes von Sinneszellen und Verfahren zur Wirkstoff-Administrationssteuerung

Also Published As

Publication number Publication date
EP1504760B1 (en) 2008-07-09
HUP0101733A2 (hu) 2001-11-28
ATE296635T1 (de) 2005-06-15
EP1058553B1 (en) 2005-06-01
JP2002505297A (ja) 2002-02-19
DE69925578T2 (de) 2006-04-27
WO1999044624A3 (en) 1999-10-21
US6423691B1 (en) 2002-07-23
PL343412A1 (en) 2001-08-13
DE69939075D1 (de) 2008-08-21
CN1298304A (zh) 2001-06-06
EP1504760A1 (en) 2005-02-09
NO20004405L (no) 2000-11-03
BR9908566A (pt) 2000-11-21
JP4422894B2 (ja) 2010-02-24
AU2745599A (en) 1999-09-20
HUP0101733A3 (en) 2001-12-28
CA2322854A1 (en) 1999-09-10
EP1058553A2 (en) 2000-12-13
AR018576A1 (es) 2001-11-28
WO1999044624A2 (en) 1999-09-10
ATE400277T1 (de) 2008-07-15
ID27083A (id) 2001-02-22
NO20004405D0 (no) 2000-09-04
DE69925578D1 (de) 2005-07-07
KR20010041605A (ko) 2001-05-25

Similar Documents

Publication Publication Date Title
HK1037861A1 (en) Formulations for the prevention or the treatment of diseases affecting mucosae or skin, or for pregnancy prevention
UA56989C2 (uk) ФІЗІОЛОГІЧНО АКТИВНИЙ ПЕГ-КОН'ЮГАТ <font face="Symbol">a</font>-ІНТЕРФЕРОНУ, СПОСІБ ЙОГО ОДЕРЖАННЯ, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ НА ЙОГО ОСНОВІ ТА СПОСІБ ЛІКУВАННЯ АБО ПРОФІЛАКТИКИ ІМУНОМОДУЛЯТОРНИХ ЗАХВОРЮВАНЬ
EP1549328A4 (en) USE OF A HUMAN SHEEP SKIN COMPOSITION FOR PROPHYLAXIS AND TREATMENT OF DISEASES AND STATES OF EYE AND SKIN
HUP9700603A3 (en) Pharmaceutical preparation for the treatment of blood coagulation disorders
AU3886199A (en) Medical device for dissolution of tissue within the human body
IL195723A (en) Use of p53 inhibitors for the preparation of medicament
IL152659A (en) Liquid pharmaceutical compositions comprising a pegylated human erythropoietin protein and a multiple charged inorganic anion, in a pharmaceutically acceptable buffer
HUP9774641A2 (en) Gel for treatment of skin diseases and for disinfection of the skin
IL178072A (en) Use of monoesters of probucol or a pharmaceutically acceptable salt thereof for preparing medicaments for the treatment of cardiovascular and inflammatory disease
IL127943A0 (en) Pharmaceutical and cosmetic composition for the treatment of skin disorders
ZA991749B (en) Pharmaceutical composition for prophylaxis and therapy of diseases associated with ocular fundus tissue cytopathy.
HUP9904317A3 (en) Use of 1-hydroxy-2-pyridones for producing pharmaceutical compositions suitable for the treatment of skin diseases
HUP0104963A3 (en) Compositions for the treatment of skin diseases
AU2001259085A1 (en) Treatment of ocular neovascularization and related diseases
AU2251302A (en) Use of the long pentraxin ptx3 for the treatment of diseases caused by an altered activation of the growth factor fgf-2
HUP0000785A3 (en) Ointment for the treatment of burns and other skin diseases
AU3401093A (en) Therapeutic agent for threatened abortion
KR100488038B1 (ko) 기관 보호 활성을 지닌 신규한 신체 보호 화합물 펩티드염, 이의 제조 방법 및 치료에서의 이의 용도
HUP0103017A3 (en) Pharmaceutical composition for the treatment of diseases caused by impairment of cognitive functions and its use
EP0687687A3 (de) Pharmazeutische Zusammensetzung zur Vorbeugung und Behandlung von Blutgerinnungsstörungen
BR9916963A (pt) Bupropiona para tratamento de doenças virais
GB9908059D0 (en) Diagnosis and treatment of diseases
NO20001895D0 (no) Anvendelse av glykosaminoglykaner for fremstilling av farmasøytiske preparater for behandling av diabetes assosierte- øyesykdommer
UA41326C2 (uk) Фармацевтична композиція для профілактики або лікування вірусних захворювань, засіб для профілактики або лікування вірусних захворювань
HUP0203309A3 (en) Therapeutic combinations of (s)-2-(benzylamino-methyl)-2,3,8,9,-tetrahydro-7h-1,4-dioxino(2,3)-e indol-8-one and neuroleptics for treatment or prevention of phychotic disorders and pharmaceutical compositions containing them